A clinical trial of hydrocortisone-17-butyrate in combination with chlorquinaldol in the treatment of infected dermatoses is reported. A total of 64 patients was treated of which 22 were children up to the age of 10 years. The results indicate this corticosteroid, in combination with chlorquinaldol, to be of substantial clinical value with a wide margin of proven clinical safety.
Get full access to this article
View all access options for this article.
References
1.
AlexanderSLyneC (1973) A Preliminary Clinical Trial of Hydrocortisone 17-Butyrate. The British Journal of Clinical Practice27 (5), 177
2.
AshurstPJC (1972) Hydrocortisone-17-Butyrate, a New Synthetic Topical Corticosteroid. The British Journal of Clinical Practice23 (6), 263
3.
British Medical Journal (1963) To-days Drugs. British Medical Journal2, 434
4.
PolanoMKSuurmondDv d LelyMAWarnaarP (1970) A Clinical Trial with Hydrocortisone Butyrate Cream in Psoriasis. British Journal of Dermatology83, 93
5.
PolanoMKKanaarP (1973) A Clinical Trial with Hydrocortisone Butyrate Cream in Eczema. British Journal of Dermatology88, 83
6.
RaabWP (1971) The interaction of Corticosteroids and antimicrobial Agents used in Topical Therapy. British Journal of Dermatology84, 582
7.
SneddonIB (1973) A Trial of Hydrocortisone Butyrate in the Treatment of Rosacea and Perioral Dermatitis. British Journal of Dermatology89, 505
